Latest DEF 14A proxy statements

Co-Diagnostics, Inc. will hold a Special Meeting on December 5, 2025, to seek shareholder approval for a reverse stock split to maintain its Nasdaq listing.

TEGNA Inc. filed supplemental disclosures to its definitive proxy statement to address shareholder lawsuits alleging misleading information regarding its merger with Nexstar Media Group.

Investcorp Credit Management BDC, Inc. announced its 2025 Annual Meeting of Stockholders to be held on December 18, 2025, primarily for the election of one director.

Applied DNA Sciences calls a Special Meeting to approve warrant exercises, increase authorized shares, and expand its equity incentive plan to support its new BNB digital asset strategy.

Anteris Technologies Global Corp. announces its 2025 Annual Meeting of Stockholders to address director elections, auditor ratification, and significant RSU grants for executives and non-employee directors.

CISO Global, Inc. is seeking stockholder approval for significant equity plan expansion, a $15 million preferred stock issuance to B. Riley, and a substantial increase in authorized common stock.

Forge Global Holdings, Inc. announced a definitive merger agreement to become a wholly-owned subsidiary of The Charles Schwab Corporation.

Theriva Biologics, Inc. is holding a Special Meeting to approve the issuance of up to 16.18 million common shares from new warrant exercises, a condition for potential capital.

Hologic, Inc. issued an internal FAQ to employees detailing the impact of its acquisition by Blackstone and TPG on benefits, bonuses, and equity awards.

Jaguar Health, Inc. calls a Special Meeting to approve the issuance of common stock related to Series N Preferred Stock exchanges and a new PIPE financing, crucial for Nasdaq compliance.

Zymeworks Inc. announced its Annual Meeting of Stockholders for December 30, 2025, to address director elections, executive compensation, and auditor ratification.

Gulf Island Fabrication, Inc. has entered into a definitive merger agreement to be acquired by IES Holdings, Inc. for $12.00 per share in cash.

Zymeworks Inc. announces its 2025 Annual Meeting of Stockholders to be held virtually on December 30, 2025, focusing on director elections, executive compensation, and auditor ratification, alongside reporting 2024 financial and operational highlights.

Cracker Barrel Old Country Store, Inc. defends its multi-year strategic plan and board nominees against an activist shareholder, highlighting FY2205 financial gains and operational adjustments.

Paramount Group's Board of Directors unanimously recommends stockholders approve a cash merger with Rithm Capital Corp. at $6.60 per share, offering a significant premium and immediate liquidity.

Brilliant Earth Group, Inc. is reincorporating from Delaware to Nevada, a move approved by its board and majority stockholders, citing a desire for greater legal predictability and stability.

TEN Holdings, Inc. is pursuing a reverse stock split, ranging from 1-for-10 to 1-for-20, to address its Nasdaq minimum bid price deficiency and maintain its listing.

Revelation Biosciences, Inc. calls a Special Meeting to approve the issuance of common stock exceeding Nasdaq's 20% cap, crucial for funding and continued listing.

Onconetix, Inc. calls for its Annual Meeting to approve significant private placement financings, elect new directors, and ratify its independent auditor.

Greenlane Holdings, Inc. announces its 2025 Annual Meeting to vote on significant equity issuances, an expanded incentive plan, and a strategic shift towards digital asset treasury management, leading to substantial shareholder dilution.

Invesco QQQ TrustSM, Series 1 is urging shareholders to vote on a modernization proposal expected to save $70 million annually in expenses.

Verint Systems Inc. has filed supplemental disclosures to its definitive proxy statement for the acquisition by Calabrio, Inc., addressing shareholder litigation and providing updated financial analysis details.

Aimei Health Technology Co., Ltd. is seeking shareholder approval to extend its business combination deadline to December 2026 and reduce sponsor extension fees to facilitate its merger with United Hydrogen.

Metsera's Board unanimously recommends an amended merger agreement with Pfizer, increasing the cash consideration to $65.60 per share and total potential value to $86.25 per share, following a competitive bidding process and regulatory scrutiny.

Grid Dynamics Holdings, Inc. has filed a definitive proxy statement with the SEC.

Grid Dynamics Holdings, Inc. will hold its 2025 Annual Meeting to elect directors, ratify auditors, vote on executive compensation, and approve an increase of 3.5 million shares for its equity incentive plan.

Dominari Holdings Inc. calls 2025 Annual Meeting to vote on director, auditor, equity plan increase, potential dilutive share issuance, and Rights Agreement renewal.

Workhorse Group Inc. reminds shareholders to vote FOR all proposals related to its merger with Motiv Power Systems, Inc. by the November 11, 2025 deadline, emphasizing it as the only viable path forward.

NanoVibronix calls 2025 Annual Meeting for votes on board, auditor, incentive plan, and private placement share issuance.

Xcel Brands, Inc. filed an amendment to its definitive proxy statement, detailing new equity awards for its Board of Directors and performance-based options for management under its 2021 Equity Incentive Plan.